The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?
Current Opinion in Psychiatry March 1, 2008 DOI: 10.1097/yco.0b013e3282f51266 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Cannabis |
| Citations | 67 |
| Key findings | The authors conclude that cannabis is unlikely to cause irreversible brain damage or psychosis through structural brain changes, and may even have benign effects on brain structure. They suggest that adverse consequences are more likely to arise from neurochemical interactions with the dopaminergic pathway, particularly in genetically vulnerable individuals. |
Abstract
Purpose: OF REVIEW: This review explores what is known about the association of cannabis with schizophrenia, its effects on the brain, and whether the brain changes known to be present in schizophrenia could be caused by cannabis and thus lead to a psychosis. RECENT
Findings: The heavy use of cannabis is known to be associated with some adverse consequences, such as the occurrence of acute psychotic episodes and the development of chronic schizophrenia in some people even after its use has terminated. Recent studies have produced controversy about whether cannabis in heavy use can cause irreversible brain damage, particularly to adolescents, and thus whether a chronic psychosis could be a result of brain changes caused by cannabis. SUMMARY: From the evidence that exists, it appears that the above view is unlikely and that cannabis may even have benign effects on brain structure, not producing deleterious damage. Its neurochemical interactions with the dopaminergic pathway, however, may, particularly in genetically vulnerable individuals, have adverse consequences.
Comparable studies
Other narrative reviews on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Causal association between cannabis and psychosis: examination of the evidence | 2004 | Review | |
| Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. General (historical and pharmacological review) | 2018 | Review | |
| Psychiatric effects of cannabis | 2001 | Review | |
| Beyond THC: The New Generation of Cannabinoid Designer Drugs | 2011 | Review | |
| Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug | 2006 | Review |
Citations in the library
Cited by 12
- The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample Schizophrenia Bulletin July 25, 2010
- Neuroimaging in cannabis use: a systematic review of the literature Psychological Medicine July 23, 2009
- Effects of Cannabis on Impulsivity: A Systematic Review of Neuroimaging Findings Current Pharmaceutical Design May 10, 2014
- Early cannabis use and its relation to the development of psychiatric disorders: a review Salud Mental December 12, 2017
- Consommation de cannabis: quels sont les risques ? Annales de Toxicologie Analytique 2008
and 7 more in the library
Cites 15
- Causal association between cannabis and psychosis: examination of the evidence The British Journal of Psychiatry January 30, 2004
- Cannabis use and psychotic disorders: an update Drug and Alcohol Review November 30, 2004
- New Perspectives in the Studies on Endocannabinoid and Cannabis: Cannabinoid Receptors and Schizophrenia Journal of Pharmacological Sciences 2004
- Functional imaging studies in cannabis users. The Neuroscientist October 2007
- Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biological Psychiatry June 1, 2007
and 10 more in the library